Axsome Therapeutics’ betadex sulfobutylether sodium containing composition: FDA Acceptance of NDA Resubmission
Axsome Therapeutics, Inc., an U.S.-based biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS)